Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $326.58 | 8 | 90.0% |
| Education | $36.43 | 4 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Outset Medical Inc | $100.82 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $84.37 | 2 | $0 (2023) |
| Amgen Inc. | $82.06 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $79.41 | 4 | $0 (2024) |
| Calliditas Therapeutics US Inc. | $13.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $232.14 | 7 | Outset Medical Inc ($100.82) |
| 2023 | $110.79 | 4 | Bayer Healthcare Pharmaceuticals Inc. ($84.37) |
| 2022 | $20.08 | 1 | Amgen Inc. ($20.08) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 10/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $61.98 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Outset Medical Inc | — | Food and Beverage | In-kind items and services | $100.82 | General |
| 10/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 08/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.93 | General |
| 06/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.38 | General |
| 04/02/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.28 | General |
| 12/12/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 11/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $59.37 | General |
| Category: Cardio-renal | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.82 | General |
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardio-renal | ||||||
| 03/23/2022 | Amgen Inc. | Tavneos (Drug) | Education | In-kind items and services | $20.08 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 655 | 1,895 | $325,835 | $192,760 |
| 2022 | 8 | 750 | 2,457 | $394,283 | $231,927 |
| 2021 | 11 | 866 | 2,235 | $398,589 | $232,796 |
| 2020 | 9 | 849 | 1,991 | $330,477 | $179,845 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 175 | 951 | $123,630 | $86,307 | 69.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 235 | 505 | $68,175 | $36,245 | 53.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 24 | 112 | $56,000 | $30,026 | 53.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 138 | 174 | $31,320 | $16,650 | 53.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 16 | 54 | $27,000 | $11,556 | 42.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 13 | 24 | $8,400 | $5,378 | 64.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $7,980 | $4,345 | 54.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 37 | $3,330 | $2,253 | 67.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 224 | 1,482 | $192,660 | $115,515 | 60.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 29 | 172 | $86,000 | $46,640 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 443 | $59,805 | $38,123 | 63.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 166 | 221 | $39,780 | $21,796 | 54.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 79 | $7,110 | $4,314 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,040 | $2,980 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 24 | $2,208 | $1,342 | 60.8% |
| 99234 | Hospital observation or inpatient care admitted and discharged on the same day for low severity problem, typically 40 minutes | Facility | 2022 | 12 | 12 | $1,680 | $1,217 | 72.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 220 | 1,107 | $143,910 | $88,292 | 61.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 37 | 199 | $99,500 | $55,352 | 55.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 358 | $48,330 | $30,947 | 64.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 176 | 212 | $38,160 | $21,491 | 56.3% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 13 | 66 | $33,000 | $14,734 | 44.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 113 | $10,396 | $7,357 | 70.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 71 | 109 | $9,810 | $6,033 | 61.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $7,280 | $4,422 | 60.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 13 | $2,353 | $1,811 | 77.0% |
About Dr. M. Ullah, M.D
Dr. M. Ullah, M.D is a Nephrology healthcare provider based in Springfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275538480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. M. Ullah, M.D has received a total of $363.01 in payments from pharmaceutical and medical device companies, with $232.14 received in 2024. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($326.58).
As a Medicare-enrolled provider, Ullah has provided services to 3,120 Medicare beneficiaries, totaling 8,578 services with total Medicare billing of $837,327. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Springfield, OH
- Active Since 06/15/2005
- Last Updated 04/07/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1275538480
Products in Payments
- Kerendia (Drug) $84.37
- TAVNEOS (Drug) $61.98
- Tavneos (Drug) $20.08
- TARPEYO (Drug) $13.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Springfield
Dr. Michael Germain, Md, MD
Nephrology — Payments: $526,036
Merry Downer, M.d, M.D
Nephrology — Payments: $121,311
Dr. Jonathan Slater, M.d, M.D
Nephrology — Payments: $87,645
Sanju Varghese, Md, MD
Nephrology — Payments: $54,504
Mr. Ramesh Marahatta, Md, MD
Nephrology — Payments: $13,383
Thomas Ebert, M.d, M.D
Nephrology — Payments: $9,270